Paul G. Allen Frontiers Group [to 1 Aug 2020]
No new digest content identified.


BARDA – U.S. Department of HHS [to 1 Aug 2020]
July 31, 2020: HHS, DOD Partner With Sanofi and GSK on Commercial-Scale Manufacturing Demonstration Project to Produce Millions of COVID-19 Investigational Vaccine Doses
[See Milestones above for detail]


BMGF – Gates Foundation [to 1 Aug 2020]
No new digest content identified.


Bill & Melinda Gates Medical Research Institute [to 1 Aug 2020]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.


CARB-X [to 1 Aug 2020]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.


CEPI – Coalition for Epidemic Preparedness Innovations [to 1 Aug 2020]
Latest News
No new digest content identified.


EDCTP [to 1 Aug 2020]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.


Emory Vaccine Center [to 1 Aug 2020]
Vaccine Center News
No new digest content identified.


European Medicines Agency [to 1 Aug 2020]
News & Press Releases
News: Global regulatory workshop on COVID-19 real-world evidence and observational studies
Last updated: 31/07/2020
Vaccines surveillance and vigilance, collaboration on pregnancy studies and building international patient cohorts were the main topics discussed during the 3rd workshop on observational studies of real-world data in the context of COVID-19. The workshop, organised under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), was co-chaired by Health Canada and the European Medicines Agency (EMA) and took place on 22 July 2020. The main findings of the workshop are summarised in a report.



News: Global regulatory workshop on COVID-19 therapeutics #2: agreement on acceptable endpoints for clinical trials
Last updated: 31/07/2020



News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020
CHMP, Last updated: 24/07/2020


European Vaccine Initiative [to 1 Aug 2020]
Latest News
No new digest content identified.


FDA [to 1 Aug 2020]
Press Announcements
July 31, 2020 – Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection

July 31, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 31, 2020

July 30, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 30, 2020

July 29, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 29, 2020

July 29, 2020 – Coronavirus (COVID-19) Update: FDA Posts New Template for At-Home and Over-the-Counter Diagnostic Tests for Use in Non-Lab Settings, Such as Homes, Offices or Schools

July 28, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 28, 2020

July 27, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 27, 2020


Fondation Merieux [to 1 Aug 2020]
News, Events
No new digest content identified.


Gavi [to 1 Aug 2020]
News releases
31 July 2020
92 low- and middle-income economies eligible to get access to COVID-19 vaccines through Gavi COVAX AMC
[See Milestones above for detail]

27 July 2020
Gavi helps immunise 65 million children in 2019, though COVID-19 puts progress under pressure
:: New analysis of WHO/UNICEF data by Gavi, the Vaccine Alliance, shows the gap in vaccine coverage between Gavi-supported lower-income countries and wealthier countries has shrunk to record lows
:: Coverage for newer vaccines, such as those that tackle pneumonia and diarrhoea, now higher in Gavi-supported countries than the global average
:: COVID-19 pandemic makes the task of reaching those children still missing out on vaccines even more urgent


GHIT Fund [to 1 Aug 2020]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.


Global Fund [to 1 Aug 2020]
COVID-19 Information
28 July 2020
Situation Report
… The Global Fund is providing up to US$1 billion and operational flexibility to help countries fight COVID-19, shore up health systems and mitigate the impacts on lifesaving HIV, TB and malaria programs. Emergency funding is available through the US$500 million COVID-19 Response Mechanism and additional grant flexibilities of up to US$500 million…
…The COVID-19 Guidance Note on Community, Rights and Gender is also available in Spanish, French and Russian…


Hilleman Laboratories [to 1 Aug 2020]
No new digest content identified.


Human Vaccines Project [to 1 Aug 2020]
No new digest content identified.


IAVI [to 1 Aug 2020]
July 31, 2020
Contributing to HIV Vaccine Research in Africa: USAID-Funded Science Capacity Building Partnership with IAVI



International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.



International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.



No new digest content identified.


IFRC [to 1 Aug 2020]
Selected Press Releases, Announcements
Red Cross in Bahamas preparing for Hurricane Isaias, while balancing COVID-19 response and Hurricane Dorian recovery
Panama/Port of Spain, 31 July 2020 — The International Federation of Red Cross and Red Crescent Societies (IFRC) is working alongside the Bahamas Red Cross to prepare for Hurricane Isaias. A hurricane warning is in effect in the Bahamas with storm surg …
31 July 2020



International Red Cross and Red Crescent Movement urges all nations to end the nuclear era
Geneva, 31 July 2020 –Seventy-five years ago, on the morning of August 6, 1945, a B-29 warplane released a terrifying new weapon on Hiroshima. The nuclear bomb wiped out the city, instantly killing an estimated 70,000 people and leaving tens of thousan …
31 July 2020

Red Cross calls on people to check on neighbours and loved ones during dangerous heatwave
As temperatures soar across Europe, the International Federation of Red Cross and Red Crescent Societies (IFRC) is calling on the public to check on neighbours and loved ones who might struggle to cope with the searing heat.
29 July 2020

Asia Pacific, Philippines
Philippines: Red Cross urges greater vigilance as COVID-19 cases fill hospitals
Manila, 28 July 2020 – Red Cross is urging everyone in the Philippines to be even more vigilant as COVID-19 cases continue to jump by more than a thousand each day following the easing of quarantine restrictions. More than 80,000 people in the country …
28 July 2020


IVAC [to 1 Aug 2020]
Joint Statement on COVID-19 Vaccines & Older Adults
July 2020
As WHO, CEPI, and Gavi meet and consider how best to manage the planning and deployment of a COVID-19 vaccine, we feel the voice of older adults, one of the most vulnerable, important, and essential groups should feature prominently in the COVAX process.

In keeping with COVAX’s stated goal of equity, we recommend:
[1] Prioritizing development of a COVID-19 vaccine that elicits a strong immune response in older adults, going beyond the stated minimum efficacy in the target product profile efficacy. To this end, recruitment of older adults in the development process is essential.
[2] Including a broader range of stakeholders with expertise in older adults both within and outside of the immunization and health sector on COVAX working groups to represent important perspectives relevant to low- and middle-income countries, particularly for vulnerable populations.
[3] Supporting efforts to evaluate current preparedness of health systems and other channels to safely deliver a COVID-19 vaccine specifically to adults and those most vulnerable.
[4] Gavi should consider support for influenza vaccines for older populations now to gain experience immunizing older groups and other vulnerable populations to protect them against further impact due to COVID-19. Global partners should also prioritize support for certain countries to strengthen their program.

These key recommendations are proposed as being part of the solution, and we strongly believe many hands and minds across sectors and disciplines are required to successfully deploy vaccines to older adults.
Download Joint Statement Here


IVI [to 1 Aug 2020]
Selected IVI News & Announcements
No new digest content identified.


JEE Alliance [to 1 Aug 2020]
Selected News and Events
No new digest content identified.


MSF/Médecins Sans Frontières [to 1 Aug 2020]
Latest [Selected Announcements]
Libya: “They were shot and killed as they fled arbitrary detention”
Project Update 31 Jul 2020

MSF forced to close COVID-19 centre on Lesbos
Press Release 30 Jul 2020

Coronavirus COVID-19 pandemic
Diagnostic company Cepheid charging four times more than it should for COVID-19 tests
Press Release 28 Jul 2020
MSF urges Cepheid to stop profiteering off the COVID-19 pandemic and lower the price of desperately-needed COVID-19 tests.


National Vaccine Program Office – U.S. HHS [to 1 Aug 2020]
NVAC Meetings
September 23-24, 2020 Meeting (Virtual)
February 4-5, 2021 NVAC Meeting
June 16-17, 2021 NVAC Meeting


NIH [to 1 Aug 2020]
Selected News Releases
NIH delivering new COVID-19 testing technologies to meet U.S. demand
Friday, July 31, 2020
The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests that could significantly increase the number, type and availability of tests by millions per week as early as September 2020. With national demand estimated to be millions more tests per day above current levels, these technologies are expected to make a significant contribution to expanding the nation’s testing capacity.

Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
July 28, 2020 — NIH-led study of mRNA vaccine supports advance to Phase 3 human trials.
Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19)  induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.  SARS-CoV-2 is the virus that causes COVID-19.
The candidate vaccine, mRNA-1273, was co-developed by scientists at the NIAID Vaccine Research Center and at Moderna, Inc., Cambridge, Massachusetts

NIH to invest $58M to catalyze data science and health research innovation in Africa
July 27, 2020 — The new five-year program will leverage existing data and technologies to develop solutions for the continent’s most pressing clinical and public health problems.

Phase 3 clinical trial of investigational vaccine for COVID-19 begins
July 27, 2020 — Multi-site trial to test candidate developed by Moderna and NIH.
A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun. The vaccine, known as mRNA-1273, was co-developed by the Cambridge, Massachusetts-based biotechnology company Moderna, Inc., and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial, which will be conducted at U.S. clinical research sites, is expected to enroll approximately 30,000 adult volunteers who do not have COVID-19..


PATH [to 1 Aug 2020]
Selected Announcements
Lifesaving umbilical cord product receives pre-qualification from West African Health Organization
July 30, 2020 by PATH
Chlorxy-G Gel, a 7.1% chlorhexidine digluconate gel manufactured in Nigeria, receives approval for introduction in 15 countries


Sabin Vaccine Institute [to 1 Aug 2020]
Statements and Press Releases
No new digest content identified.


UNAIDS [to 1 Aug 2020]
Selected Press Releases/Reports/Statements
30 July 2020
Celebrating the life of Inviolata Mbwavi, Kenyan AIDS activist

29 July 2020
Guyana community organization serves sex workers on the edge during COVID-19

28 July 2020
#TogetherWeWin: inspiring examples of solidarity during the COVID-19 outbreak in eastern Europe and central Asia


UNICEF [to 1 Aug 2020]
Selected Press releases/Announcements
Press release
UNICEF and faith groups release new guidance on how to support communities in times of COVID-19
Guidance advises faith leaders and communities on how to practice faith safely, fight misinformation, and support children and vulnerable populations

Press release
A third of the world’s children poisoned by lead, new groundbreaking analysis says
UNICEF and Pure Earth call for urgent action to abolish dangerous practices including the informal recycling of lead acid batteries

Five children killed and nine injured in an attack on a village in West Darfur, Sudan
Statement from Mohammed Ould Bouasria, Acting UNICEF Representative in Sudan

Press release
UNICEF: An additional 6.7 million children under 5 could suffer from wasting this year due to COVID-19
As part of its Reimagine campaign, UNICEF calls for accelerated action to prevent and treat malnutrition caused by pandemic as humanitarian community appeals for $2.4 billion to improve maternal and child nutrition


Unitaid [to 1 Aug 2020]
Featured News
28 July 2020
Unitaid celebrates progress against hepatitis C through simpler medicines and tests
Geneva – On the occasion of World Hepatitis Day, Unitaid celebrates the progress made in the fight against Hepatitis C in the past few years. Notably, thanks to quality medicines and tests that are simpler to administer, affordable and adapted to the needs of people in low- and middle-income countries.
Close to 400,000 people continue dying of Hepatitis C globally each year. Antiviral medicines can cure more than 95 percent of people with the infection, but access to diagnosis and treatment has typically been low. Less than a decade ago, Hepatitis C was difficult and expensive to treat even in high-income countries, and new medicines where out of reach for people in lower-income countries…


Vaccination Acceptance Research Network (VARN) [to 1 Aug 2020]
No new digest content identified.


Vaccine Confidence Project [to 1 Aug 2020]
Latest News & Archive
Public sentiments and emotions around COVID-19
1 Aug 2020


Vaccine Education Center – Children’s Hospital of Philadelphia [to 1 Aug 2020]
No new digest content identified.


Wellcome Trust [to 1 Aug 2020]
Opinion | 29 July 2020
How can we make social media a healthier platform for health information?
Carla Ross, Research and Evidence Lead, Wellcome
It’s time to see health misinformation differently. We’re calling for the health and research sector to step up and play its role in creating a healthier internet.


The Wistar Institute [to 1 Aug 2020]
Press Releases
Jul. 28, 2020
The Wistar Institute and Cheyney University Forge Strategic Collaboration to Expand Life Science Research Training and Business Development Opportunities in Pennsylvania
Collaboration extends impact of Wistar’s biomedical science and workforce development programs and Cheyney University’s educational and entrepreneurial communities


WFPHA: World Federation of Public Health Associations [to 1 Aug 2020]
Latest News
No new digest content identified.


World Organisation for Animal Health (OIE) [to 1 Aug 2020]
No new digest content identified.





ARM [Alliance for Regenerative Medicine] [to 1 Aug 2020]
Press Releases
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
July 29, 2020


BIO [to 1 Aug 2020]
Press Releases
No new digest content identified.


DCVMN – Developing Country Vaccine Manufacturers Network [to 1 Aug 2020]
News; Upcoming events
No new digest content identified.


IFPMA [to 1 Aug 2020]
Selected Press Releases, Statements, Publications
IFPMA Points to Consider for Virtual GMP Inspections – an Industry perspective
29 July 2020


ICBA – International Council of Biotechnology Associations [to 1 Aug 2020]
No new digest content identified.


PhRMA [to 1 Aug 2020]
Selected Press Releases, Statements
No new digest content identified.